share_log

Pfizer | DEFA14A: Others

Pfizer | DEFA14A: Others

輝瑞 | DEFA14A：其他
美股sec公告 ·  03/28 16:17
Moomoo AI 已提取核心訊息
Pfizer Inc. has issued a supplement to its proxy statement for the upcoming 2024 Annual Meeting of Shareholders scheduled for April 25, 2024. The supplement, dated March 28, 2024, informs shareholders of the withdrawal of Item 7 – Amend Director Resignation Processes, which will no longer be presented or voted upon at the meeting. Despite the withdrawal of Item 7, Pfizer has confirmed that the previously distributed proxy cards and voting instruction forms remain valid. Shareholders who have already submitted their votes do not need to take any further action unless they wish to change their vote. The supplement emphasizes that all other agenda items are unaffected and votes will be cast accordingly for matters properly brought before the Annual Meeting. Shareholders who have not yet voted are instructed to disregard Item 7 when completing their proxy cards or voting instruction forms.
Pfizer Inc. has issued a supplement to its proxy statement for the upcoming 2024 Annual Meeting of Shareholders scheduled for April 25, 2024. The supplement, dated March 28, 2024, informs shareholders of the withdrawal of Item 7 – Amend Director Resignation Processes, which will no longer be presented or voted upon at the meeting. Despite the withdrawal of Item 7, Pfizer has confirmed that the previously distributed proxy cards and voting instruction forms remain valid. Shareholders who have already submitted their votes do not need to take any further action unless they wish to change their vote. The supplement emphasizes that all other agenda items are unaffected and votes will be cast accordingly for matters properly brought before the Annual Meeting. Shareholders who have not yet voted are instructed to disregard Item 7 when completing their proxy cards or voting instruction forms.
輝瑞公司已發佈了定於2024年4月25日舉行的2024年年度股東大會的委託書補充文件。該補編於2024年3月28日發佈，通知股東撤回第7項——修改董事辭職程序，該項目將不再在會議上提交或表決。儘管撤回了第7項，但輝瑞已確認先前分發的代理卡和投票指示表仍然有效。已經提交選票的股東無需採取任何進一步的行動，除非他們希望更改投票。該補編強調，所有其他議程項目均不受影響，將對適當提交年會的事項進行相應的投票。尚未投票的股東被指示在填寫代理卡或投票指示表時忽略第7項。
輝瑞公司已發佈了定於2024年4月25日舉行的2024年年度股東大會的委託書補充文件。該補編於2024年3月28日發佈，通知股東撤回第7項——修改董事辭職程序，該項目將不再在會議上提交或表決。儘管撤回了第7項，但輝瑞已確認先前分發的代理卡和投票指示表仍然有效。已經提交選票的股東無需採取任何進一步的行動，除非他們希望更改投票。該補編強調，所有其他議程項目均不受影響，將對適當提交年會的事項進行相應的投票。尚未投票的股東被指示在填寫代理卡或投票指示表時忽略第7項。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息